Evidence map›Paper›PMID 35752559›Full record

ArticleThe journal of sexual medicine2022

Sonic Hedgehog Signaling in Primary Culture of Human Corpora Cavernosal Tissue From Prostatectomy, Diabetic, and Peyronie's Patients.

Sarah Martin, Jiangping Deng, Timothy Searl, Samuel Ohlander, Daniel A Harrington, Samuel I Stupp, Danuta Dynda, Kevin T McVary, Carol A Podlasek

Open access · greenAbstract read
In one paragraph

Article in The journal of sexual medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Sarah MartinDepartment of Urology, University of Illinois at Chicago, Chicago, IL.
Jiangping DengDepartment of Urology, University of Illinois at Chicago, Chicago, IL.
Timothy SearlDepartment of Urology, University of Illinois at Chicago, Chicago, IL.
Samuel OhlanderDepartment of Urology, University of Illinois at Chicago, Chicago, IL.
Daniel A HarringtonUTHealth, The University of Texas Health Science Center at Houston, Department of Diagnostic and Biomedical Sciences, Houston, TX.
Samuel I StuppSimpson Querrey Institute, Departments of Chemistry, Materials Science and Engineering, Biomedical Engineering, and Medicine, Evanston, IL.
Danuta DyndaDivision of Urology, Southern Illinois University School of Medicine, Springfield, IL.
Kevin T McVaryDepartment of Urology, Loyola University Stritch School of Medicine, Maywood, IL.
Carol A PodlasekDepartments of Urology, Physiology, Bioengineering, and Biochemistry, University of Illinois at Chicago, Chicago, IL. Electronic address: cap325@uic.edu.
University of Illinois Chicago · USEvanston Hospital · USLoyola University Chicago · USSouthern Illinois University School of Medicine · USThe University of Texas Health Science Center at Houston · US

Funding

3-Way Approach for ED PreventionR01DK101536 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Carol Ann Podlasek · 2014 to 2026
$5.9M
NIDDK NIH HHS R01 DK101536
6 · The paper itself

Abstract

backgroundCavernous nerve (CN) injury causes penile remodeling, including smooth muscle apoptosis and increased collagen, which results in erectile dysfunction (ED), and prevention of this remodeling is critical for novel ED therapy development.

aimWe developed 2 peptide amphiphile (PA) hydrogel delivery vehicles for Sonic hedgehog (SHH) protein to the penis and CN, which effectively suppress penile distrophic remodeling (apoptosis and fibrosis), in vivo in a rat CN injury model, and the aim of this study is to determine if SHH PA can be used to regenerate human corpora cavernosal smooth muscle deriving from multiple ED origins.

methodsCorpora cavernosal tissue was obtained from prostatectomy, diabetic, hypertension, cardiovascular disease and Peyronie's (control) patients (n = 21). Primary cultures (n = 21) were established, and corpora cavernosal cells were treated with SHH protein, MSA (control), 5E1 SHH inhibitor, and PBS (control). Growth was quantified by counting the number of cells at 3-4 days. Statistics were performed by ANOVA with Scheffe's post hoc test. Concentration of SHH protein for maximal growth was optimized, and a more active SHH protein examined. OUTCOMES: Cultures were characterized by immunohistochemical analysis with ACTA2, CD31, nNOS and P4HB, and smooth muscle was quantified in comparison to DAPI.

resultsCultures established were >97% smooth muscle. SHH protein increased growth of smooth muscle cells from prostatectomy, diabetic, and Peyronie's patients in a similar manner (49%-51%), and SHH inhibition decreased growth (20%-33%). There was no difference in growth using 25 ug and 10 ug SHH protein, suggesting a threshold concentration of SHH protein above which smooth muscle growth is enhanced. A more active lipid modified SHH peptide further enhanced growth (15%), indicating a more robust growth response. SHH increased growth in smooth muscle cells from hypertension (37%) and cardiovascular disease (32%) patients. SHH protein increased growth under normal and high glucose conditions, suggesting that high glucose conditions that may be present in under controlled diabetic patients would not detract from SHH regenerative capacity. CLINICAL IMPLICATIONS: SHH PA would be beneficial to enhance smooth muscle regeneration in patients with ED of multiple etiologies. STRENGTHS AND LIMITATIONS: Understanding how human corpora cavernosal tissue responds to SHH treatment is critical for clinical translation of SHH PA to ED patients.

conclusionCorpora cavernosal smooth muscle from all ED patients responded to SHH treatment with increased growth. Stupp, SI. Sonic Hedgehog Signaling in Primary Culture of Human Corpora Cavernosal Tissue From Prostatectomy, Diabetic, and Peyronie's Patients. J Sex Med 2022;19:1228-1242.

Indexed as

Cardiovascular DiseasesDiabetes MellitusErectile DysfunctionHypertensionAnimalsGlucoseHedgehog ProteinsHumansMalePenisPeptidesProstatectomyRatsGlucoseHedgehog ProteinsPeptidesDiabetesErectile DysfunctionPeyronie'sProstatectomySmooth MuscleSonic Hedgehog

Identifiers

PMID35752559
PMCPMC9329230
OpenAlexW4283324993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.